Several sessions at the 2026 American Association of Nurse Practitioners National Conference in Las Vegas, NV, addressed migraine-related diagnosis, treatment, red flags, and care considerations across...
At the American Headache Society 68th Annual Scientific Meeting, Yaseen Agbaria, PhD, received the Harold G. Wolff Lecture Award for the best new paper on headache or facial pain. In their paper, Agbaria...
Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
In an Early Career Lecture Award study presented at the American Headache Society 68th Annual Scientific Meeting, nitroglycerin provoked headache and vestibular symptoms in participants with definite...
Physicians managing chronic migraine may be interested in new comparative patient-reported data from the FORWARD study, which evaluated treatment satisfaction with onabotulinumtoxinA versus topiramate. In...
The results from a recent randomized controlled trial showed that ultrasound-guided sphenopalatine ganglion (SPG) and greater occipital nerve blocks are equally effective in reducing headache frequency,...
This phase 4 study assessed the long-term safety and tolerability of once-daily oral rimegepant (75 mg) in adults with episodic migraine to inform clinicians about its preventive treatment profile.
